SANUWAVE Health Inc.
NASDAQRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- SANUWAVE Health, Inc. (SNWV) develops and commercializes noninvasive medical devices utilizing shockwave and ultrasound technologies to promote regenerative healing in skin, musculoskeletal, and vascular tissues. The company offers the UltraMIST system, which delivers low-frequency, non-contact ultrasound energy through a saline mist for treating acute and chronic wounds including diabetic foot ulcers, pressure ulcers, and burns; the dermaPACE system, employing Pulsed Acoustic Cellular Expression (PACE) technology for first-line treatment of diabetic wounds and pressure ulcers; and the orthoPACE system, designed for orthopedic, trauma, and sports injury applications such as bone healing and chronic tendonitis. SANUWAVE operates in the United States and internationally, with a focus on wound care, orthopedics, and regenerative medicine markets served by hospitals, clinics, and government facilities including the VA and military bases; it was founded in 2004 and is headquartered in Eden Prairie, Minnesota. In February 2024, the company entered a strategic partnership with Premier Shockwave to distribute dermaPACE into VA, Indian Health Services, and military base markets; it announced Q3 FY2025 financial results in late 2025, reflecting ongoing production ramp-up for UltraMIST systems and anticipation of expanded manufacturing capacity into 2026; a previously proposed merger with SEP Acquisition Corp. was terminated in June 2024.
Sanuwave Health Reports Preliminary Q2 2026 Revenue of $9.6–$9.8 Million, Above High End of Revised Guidance
Sanuwave Health Updates Second Quarter 2026 Guidance
Sanuwave Health Q1 Earnings Call Highlights
SANUWAVE Health, Inc. (SNWV) Q1 2026 Earnings Call Transcript
Sanuwave Health Inc. (SNWV) Reports Q1 Loss, Beats Revenue Estimates
Sanuwave Announces Revenues and Financial Results for Q1 FY2026
Sanuwave Will Host a Conference Call on May 13, 2026 at 8:30 AM (ET) to Present Q1 2026 Financial Results
Sanuwave Will Host a Conference Call on May 13, 2026 at 8:30 AM (ET) to Present Q1 2026 Financial Results
Sanuwave Health Inc. (SNWV) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
Ayr Wellness (OTCMKTS:AYRWF) and Sanuwave Health (NASDAQ:SNWV) Financial Analysis
SANUWAVE Health Inc (SNWV) Shares Fall 7.2% -- GF Value Says Still Overvalued
Head to Head Survey: Sanuwave Health (NASDAQ:SNWV) and INLIF (NASDAQ:INLF)
SANUWAVE Health, Inc. (SNWV) Q4 2025 Earnings Call Transcript
Sanuwave Announces Record Revenues and Financial Results for Q4 and Full Year 2025
Sanuwave Will Host a Conference Call on March 27, 2026 at 8:30 AM (ET) to Present Q4 and Full Year 2025 Financial Results
SANUWAVE Health (OTCMKTS:SNWV) and Arch Therapeutics (OTCMKTS:ARTH) Critical Review
Sanuwave Health Announces Preliminary Q4 2025 Revenue of $13.3–$13.4 Million, Up 29–30% Year-over-Year; Achieves Record Quarterly and Full-Year Revenue
Head to Head Analysis: SANUWAVE Health (OTCMKTS:SNWV) & InfuSystem (NYSE:INFU)
Reviewing Carmell (NASDAQ:CTCX) and SANUWAVE Health (OTCMKTS:SNWV)
AWM Investment Company Inc. Sells 23,680 Shares of Sanuwave Health Inc. $SNWV